FICO
Fair Isaac Corporation · Technology · Software - Application
$661.25
-0.08% today · -23.39% 1W
Oct 2 close or latest
PreviewWhy it's moving
Analyst cuts weighing on the stock
- FICO −0.08% on the last session vs SPY +0.74%: −0.8 pts of stock-specific move.
- Aftermath, analyst downgrade (Oct 1): After its 2 analyst downgrades in the past 5 years, FICO typically gained 2.1% over the next day (median) and was higher 50% of the time. An ordinary day: +0.2%. (Low confidence: few independent periods.)
- 1 Reddit mentions in the past 24 hours, 73% positive over the week.
- 6 analyst actions in the past 10 days (0 positive, 6 negative); latest: Barclays maintained Overweight, lowered target $935 → $875.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Meta Analyst score · Buy (+0.69)
Every firm's latest rating in the past year, each weighted by its age (a 3-month-old call counts half as much as today's), blended with the consensus of 21 analysts (+0.67, counted like 1.5 fresh ratings). 13 firms, 9 with a call in the past 3 months; net -1 upgrade in the past 30 days.
| Firm | Latest rating | Date | Weight |
|---|---|---|---|
| Barclays | Overweight | Oct 2, 2026 | 10% |
| Baird | Outperform | Oct 2, 2026 | 10% |
| Wells Fargo | Overweight | Sep 30, 2026 | 10% |
| BMO Capital | Outperform | Sep 30, 2026 | 10% |
| B of A Securities | Neutral downgrade | Sep 30, 2026 | 10% |
| UBS | Neutral | Aug 12, 2026 | 7% |
| Wolfe Research | Peer Perform downgrade | Aug 3, 2026 | 6% |
| Needham | Buy | Jul 30, 2026 | 6% |
| RBC Capital | Outperform | Jul 30, 2026 | 6% |
| Jefferies | Buy | May 4, 2026 | 3% |
| JP Morgan | Neutral | Apr 30, 2026 | 3% |
| Mizuho | Outperform | Apr 16, 2026 | 3% |
Mean target
$1,207.05
+82.5% upside
Median target
$1,150.00
+73.9% upside
Target range
490.00–1,750.00
low to high
Analysts
21
as of Oct 5
Price vs. targets
Low $490
Mean $1,207
High $1,750
Now $661.25
Consensus
Strong buy 4Buy 8Hold 7Sell 2Strong sell 0
Rating and target changes
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| Oct 2, 2026 | Barclays | Lowered target | Overweight | $935.00 → $875.00 |
| Oct 2, 2026 | Baird | Lowered target | Outperform | $1,549.00 → $1,070.00 |
| Sep 30, 2026 | Wells Fargo | Lowered target | Overweight | $1,350.00 → $950.00 |
| Sep 30, 2026 | Barclays | Lowered target | Overweight | $1,700.00 → $935.00 |
| Sep 30, 2026 | BMO Capital | Lowered target | Outperform | $1,550.00 → $1,150.00 |
| Sep 30, 2026 | B of A Securities | Downgrade | Buy → Neutral | $1,400.00 → $700.00 |
| Sep 22, 2026 | Wells Fargo | Lowered target | Overweight | $1,450.00 → $1,350.00 |
| Aug 12, 2026 | UBS | Lowered target | Neutral | $1,200.00 → $1,130.00 |
| Aug 10, 2026 | Barclays | Lowered target | Overweight | $1,950.00 → $1,700.00 |
| Aug 3, 2026 | Wolfe Research | Downgrade | Outperform → Peer Perform | — |
| Jul 30, 2026 | Needham | Reiterated | Buy | $1,650.00 |
| Jul 30, 2026 | Wells Fargo | Raised target | Overweight | $1,400.00 → $1,450.00 |
| Jul 30, 2026 | RBC Capital | Lowered target | Outperform | $2,400.00 → $1,525.00 |
| Jul 2, 2026 | UBS | Raised target | Neutral | $1,250.00 → $1,270.00 |
| Jun 16, 2026 | UBS | Raised target | Neutral | $1,110.00 → $1,250.00 |
| Jun 9, 2026 | Needham | Reiterated | Buy | $1,650.00 |
| May 19, 2026 | B of A Securities | Lowered target | Buy | $1,550.00 → $1,400.00 |
| May 4, 2026 | Jefferies | Lowered target | Buy | $1,800.00 → $1,700.00 |
| Apr 30, 2026 | Wells Fargo | Lowered target | Overweight | $1,650.00 → $1,400.00 |
| Apr 30, 2026 | JP Morgan | Lowered target | Neutral | $1,325.00 → $1,225.00 |
| Apr 29, 2026 | Needham | Lowered target | Buy | $1,975.00 → $1,650.00 |
| Apr 23, 2026 | Wells Fargo | Lowered target | Overweight | $2,300.00 → $1,650.00 |
| Apr 23, 2026 | UBS | Lowered target | Neutral | $1,200.00 → $1,150.00 |
| Apr 16, 2026 | Mizuho | Initiated | Outperform | $1,416.00 |
| Apr 10, 2026 | Barclays | Lowered target | Overweight | $2,400.00 → $1,950.00 |
| Apr 2, 2026 | Goldman Sachs | Lowered target | Buy | $1,770.00 → $1,528.00 |
| Mar 24, 2026 | Baird | Lowered target | Outperform | $1,960.00 → $1,547.00 |
| Mar 24, 2026 | JP Morgan | Lowered target | Neutral | $1,825.00 → $1,325.00 |
| Mar 18, 2026 | Wells Fargo | Lowered target | Overweight | $2,500.00 → $2,300.00 |
| Mar 11, 2026 | UBS | Lowered target | Neutral | $1,500.00 → $1,350.00 |
| Feb 3, 2026 | Goldman Sachs | Lowered target | Buy | $2,070.00 → $1,770.00 |
| Jan 29, 2026 | Needham | Reiterated | Buy | $1,975.00 |
| Jan 16, 2026 | Jefferies | Raised target | Buy | $2,100.00 → $2,200.00 |
| Jan 14, 2026 | Wells Fargo | Raised target | Overweight | $2,400.00 → $2,500.00 |
| Nov 6, 2025 | BMO Capital | Lowered target | Outperform | $2,300.00 → $2,200.00 |
| Nov 6, 2025 | Baird | Raised target | Outperform | $1,900.00 → $1,960.00 |
| Nov 6, 2025 | Jefferies | Lowered target | Buy | $2,150.00 → $2,100.00 |
| Nov 6, 2025 | JP Morgan | Raised target | Neutral | $1,750.00 → $1,825.00 |
| Oct 14, 2025 | Wells Fargo | Raised target | Overweight | $2,300.00 → $2,400.00 |
| Oct 2, 2025 | Needham | Reiterated | Buy | $1,950.00 |
Source: Yahoo Finance analyst data, collected daily.